Skip to content

A Novel Strategy for Endoscopic Dual-instrument Retrieval of Upper GI Foreign Body

A Novel Strategy for Endoscopic Dual-instrument Retrieval of Upper GI Foreign Body

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07649382
Enrollment
10
Registered
2026-06-16
Start date
2025-10-01
Completion date
2026-12-01
Last updated
2026-08-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Foreign Body Ingestion

Keywords

foreign body

Brief summary

We describe a single-center, retrospective case series (n = 10) for the utilization of dual instruments to extract foreign body at physiological narrowing. Foreign bodies that failed to remove with a single instrument or located in physiological narrowing into the duodenal bulb or descending duodenum were considered appropriate for this technique. Informed consent was obtained from all patients before the procedure.

Interventions

None listed

Sponsors

Shanghai Zhongshan Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

-Consecutive patients who underwent dual-instrument endoscopic retrieval for upper gastrointestinal foreign bodies at our center during the study period.

Exclusion criteria

-Patients with incomplete clinical or procedural records. Patients lost to follow-up immediately after the procedure.

Design outcomes

Primary

MeasureTime frameDescription
Successful Endoscopic Foreign Body Removal Rate1 dayPercentage of patients in whom the foreign body is completely removed using the dual-instrument endoscopic retrieval technique without the need for surgical intervention. Success will be assessed by direct endoscopic visualization and procedural records.

Secondary

MeasureTime frameDescription
Procedure-Related Adverse Event Rate1 weekPercentage of patients experiencing procedure-related adverse events, including mucosal injury, bleeding, perforation, aspiration, or infection. Adverse events will be assessed based on endoscopic findings, clinical evaluation, and post-procedural medical records.

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Aug 6, 2026